Unicycive Therapeutics Inc (UNCY) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Unicycive Therapeutics Inc  (NASDAQ: UNCY)

Unicycive Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information




UNCY Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 69.42 % 56.52 % 37.76 %
Gross Margin (Q2 TTM) - 68.71 % 55.57 % 37.73 %
Gross Profit Margin 5 Yr. Avg. - 66.08 % 54.71 % 32.75 %
EBITDA Margin (Q2 MRQ) - 31.9 % 25.59 % 21.79 %
EBITDA Margin (Q2 TTM) - 29.75 % 23.74 % 19.44 %
EBITDA Margin 5 Yr. Avg. - 40.53 % 30.23 % 22.74 %
Operating Margin (Q2 MRQ) - 22.61 % 18.82 % 16.03 %
Operating Margin (Q2 TTM) - 18.58 % 15.76 % 15.3 %
Operating Margin 5 Yr. Avg. - 15.26 % 14.36 % 15.96 %
Pre-Tax Profit Margin (Q2 MRQ) - 19.11 % 14.03 % 12.73 %
Pre-Tax Profit Margin (Q2 TTM) - 16.4 % 12.05 % 11.94 %
Pre-Tax Profit Margin 5 Yr. Avg. - 13.62 % 10.83 % 11.56 %
Net Margin (Q2 MRQ) - 15.69 % 11.3 % 10.34 %
Net Margin (Q2 TTM) - 14.92 % 10.68 % 9.72 %
Net Margin 5 Yr. Avg. - 7.44 % 6.8 % 9.04 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) - -0.05 % -0.03 % 0.58 %
Free Cash Flow Margin (Q2 TTM) - 17.66 % 13.26 % 7.71 %
Free Cash Flow Margin 5 Yr. Avg. - 23.43 % 17.59 % 16.03 %
Net Cash Flow Margin (Q2 MRQ) - -0.03 % -0.02 % 0.19 %
Net Cash Flow Margin (Q2 TTM) - -1.97 % -1.62 % 0.35 %
Net Cash Flow Margin 5 Yr. Avg. - 5.43 % 4.29 % 11.75 %
Effective Tax Rate (Q2 MRQ) - 17.77 % 20.54 % 19.65 %
Effective Tax Rate (Q2 TTM)